Fluorescent Beta-Lactam Conjugates for PBP Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting penicillin-binding proteins (PBPs) in bacteria are either hazardous due to radiolabeled compounds or lack specificity, making them unsuitable for routine or large-scale analysis and in vivo visualization.

Innovation Solution

Development of conjugates comprising a β-lactam antibiotic linked with a fluorescent tag, allowing selective labeling and visualization of specific PBPs through binding, enabling activity-dependent detection and modulation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If radiolabeled β-lactam is used for detecting PBPs, then detection capability is achieved, but safety hazards and handling difficulty arise

Engineering Contradiction:
ImprovePBP detection capabilityVSAvoidradiation hazard
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent changes the detection parameter from radiolabeling to fluorescent labeling. The conjugates use fluorophores (such as fluorescein, rhodamine, or cyanine dyes) attached to β-lactam antibiotics, allowing detection of PBPs through fluorescence instead of radioactivity. This maintains detection capability while eliminating radiation hazards associated with radiolabeled compounds.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs non-radioactive fluorescent probes that are safer, easier to handle, and do not require special radioactive waste disposal procedures. These fluorescent conjugates can be used routinely without the long-term safety concerns and regulatory burdens associated with radiolabeled compounds.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Ease of operation

If fluorescent labeling is used for visualizing proteins, then ease of operation is improved, but specificity is lost due to general protein tagging

Engineering Contradiction:
Improvevisualization capabilityVSAvoidPBP detection specificity
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The patent segments the PBP detection by creating multiple specialized conjugates, each with different β-lactam structures that selectively bind to specific PBP classes. For example, some conjugates are designed to target class A PBPs while others target class B or C PBPs, enabling selective visualization of different PBP groups within the same system.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent applies local quality by modifying specific regions of the β-lactam structure to confer selectivity for particular PBP types. By altering substituents on the β-lactam ring or the R1-R6 positions, the conjugates achieve localized specificity for different PBP active sites while maintaining the overall fluorescent labeling capability.

Inventive Principle:
Principle #3Local quality

3Loss of time

If activity-based probes are used for labeling, then temporal resolution is improved, but complexity of the system increases

Engineering Contradiction:
Improvetemporal resolutionVSAvoidconjugate system complexity
Core Design Contradiction:
Loss of timeVSDevice complexity

Solution Approach 1:

The patent creates a universal platform of fluorescent β-lactam conjugates that can detect multiple PBP types through a common mechanism. All conjugates share the same fundamental structure—a fluorophore attached to a β-lactam antibiotic—and rely on the same acyl-enzyme formation mechanism, simplifying the overall system despite the variety of specific conjugates available.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The conjugates provide a safer, more specific, and temporally resolved method for detecting PBPs in vivo, allowing for the visualization of specific PBPs in bacterial cells, overcoming the limitations of existing techniques.

Implementation Method 1

Penicillin potentiates PBP function by forming a stable acyl-enzyme intermediate with this residue, which in turn inhibits crosslinking of PG

Methodology Applied
Scientific EffectAcyl-enzyme intermediate formation: Enzyme

Implementation Method 2

Y is azide, (C2-C8)alkynyl, 3-8 membered cycloalkyl comprising at least one triple bond, 1,2,4,5-tetrazinyl which is optionally substituted with (C1-C8)alkyl, a fluorescent group, or biotin

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS11022602B2Antibiotic-based conjugates and methods of use thereof
Publication Date: 2021.06.01 REGENTS OF THE UNIVERSITY OF MINNESOTA
  • US11022602B2 patent drawing
  • US11022602B2 patent drawing
  • US11022602B2 patent drawing

AI summary

The invention provides a conjugate of formula I:R-L-Y   Ior a salt thereof, wherein R, L, and Y have any of the values described in the specification, as well as compositions comprising a conjugate of formula I. The conjugates are useful for labeling.